TCR2 Therapeutics Inc.
USD1.48
+0.00 (+0.00%)
CEO
Garry E. Menzel
IPO Date
2019-02-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.58
Prev. Close
$1.48
Day Low
$1.48
Day High
$1.48
52W Low
$0.82
52W High
$3.88
Market Cap
$0.06B
Volume
3.75M
| -1.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -28.4% | -27.3% | 0.00 | 26.64 | -12.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -29.7% | -28.2% | 0.00 | 21.66 | -6.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 28.3% | -18.7% | 0.00 | 22.96 | -14.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 49.7% | -59.3% | 0.00 | 16.82 | -5.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 83.4% | -54.3% | 0.00 | 17.92 | -7.8 |
| -0.2 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -15.4% | -11.2% | 0.29 | 5.02 | -0.6 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -14.0% | -10.3% | 0.28 | 5.60 | -0.9 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -11.4% | -9.0% | 0.21 | 8.01 | -0.9 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -9.9% | -8.6% | 0.09 | 14.84 | -1.6 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -8.6% | -7.6% | 0.09 | 18.35 | -3.1 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -7.4% | -6.6% | 0.08 | 21.76 | -6.4 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -6.2% | -5.4% | 0.11 | 32.60 | -9.5 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | -7.8% | -7.5% | 0.00 | 26.64 | -14.0 |